IMITREX tablet indications and usage: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 9: | Line 9: | ||
====Limitations of Use==== | ====Limitations of Use==== | ||
* Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with IMITREX, reconsider the diagnosis of migraine before IMITREX is administered to treat any subsequent attacks. | * Use only if a clear diagnosis of [[migraine]] headache has been established. If a patient has no response to the first migraine attack treated with IMITREX, reconsider the diagnosis of migraine before IMITREX is administered to treat any subsequent attacks. | ||
* IMITREX is not indicated for the prevention of migraine attacks. | * IMITREX is not indicated for the prevention of [[migraine]] attacks. | ||
* Safety and effectiveness of IMITREX Tablets have not been established for cluster headache.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = IMITREX (SUMATRIPTAN SUCCINATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=584abe73-8290-4484-ff8e-5890831c095e | publisher = | date = | accessdate = }}</ref> | * Safety and effectiveness of IMITREX Tablets have not been established for [[cluster headache]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = IMITREX (SUMATRIPTAN SUCCINATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=584abe73-8290-4484-ff8e-5890831c095e | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== |
Latest revision as of 07:47, 1 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Indications and Usage
IMITREX® Tablets are indicated for the acute treatment of migraine with or without aura in adults.
Limitations of Use
- Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with IMITREX, reconsider the diagnosis of migraine before IMITREX is administered to treat any subsequent attacks.
- IMITREX is not indicated for the prevention of migraine attacks.
- Safety and effectiveness of IMITREX Tablets have not been established for cluster headache.[1]
References
Adapted from the FDA Package Insert.